Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy

Conditions:   Non-seminomatous Germ Cell Tumors;   MetastasisInterventions:   Other: K5-RGD PET;   Other: FDGSponsor:   Centre Francois BaclesseRecruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials